Literature DB >> 16839865

Versican degradation and vascular disease.

Richard D Kenagy1, Anna H Plaas, Thomas N Wight.   

Abstract

Versican is an abundant proteoglycan in the blood vessel wall that is increased after vascular injury and accumulates in advanced atherosclerotic plaques. Versican is a large molecule with domains that mediate binding to cytokines, enzymes, lipoproteins, other extracellular matrix molecules, and signaling receptors. There is evidence that versican exists in the normal, as well as the diseased, vessel wall as discrete fragments, which represent these functional domains. We review the literature on versican degradation in vascular tissue and the function of versican domains, all of which suggest that proteolytic modification of versican may have physiologic as well as pathologic implications for the vascular system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16839865      PMCID: PMC3169384          DOI: 10.1016/j.tcm.2006.03.011

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  55 in total

1.  Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis.

Authors:  Scott A Berceli; Mark G Davies; Richard D Kenagy; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2002-12       Impact factor: 4.268

Review 2.  New strategies to prevent restenosis.

Authors:  M Kester; P Waybill; M Kozak
Journal:  Am J Cardiovasc Drugs       Date:  2001       Impact factor: 3.571

3.  Atherosclerosis: testing the water.

Authors:  Enrico Di Cera
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-01       Impact factor: 8.311

4.  A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases.

Authors:  Aloke V Finn; Herman K Gold; Anita Tang; Deena K Weber; Thomas N Wight; Allen Clermont; Renu Virmani; Frank D Kolodgie
Journal:  J Vasc Res       Date:  2002 Sep-Oct       Impact factor: 1.934

Review 5.  Versican: a versatile extracellular matrix proteoglycan in cell biology.

Authors:  Thomas N Wight
Journal:  Curr Opin Cell Biol       Date:  2002-10       Impact factor: 8.382

6.  Evidence for a proinflammatory and proteolytic environment in plaques from endarterectomy segments of human carotid arteries.

Authors:  Marilena Formato; Miriam Farina; Rita Spirito; Marco Maggioni; Anna Guarino; Gian Mario Cherchi; Paolo Biglioli; Celina Edelstein; Angelo M Scanu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-30       Impact factor: 8.311

7.  Versican undergoes specific alterations in the fine molecular structure and organization in human aneurysmal abdominal aortas.

Authors:  A D Theocharis; I Tsolakis; A Hjerpe; N K Karamanos
Journal:  Biomed Chromatogr       Date:  2003-09       Impact factor: 1.902

8.  Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1.

Authors:  Robert P T Somerville; Jean-Michel Longpre; Katherine A Jungers; J Michael Engle; Monique Ross; Stephen Evanko; Thomas N Wight; Richard Leduc; Suneel S Apte
Journal:  J Biol Chem       Date:  2003-01-03       Impact factor: 5.157

9.  Chondroitin sulfate anticoagulant activity is linked to water transfer: relevance to proteoglycan structure in atherosclerosis.

Authors:  Maria McGee; William D Wagner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-08-14       Impact factor: 8.311

10.  Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment.

Authors:  Ick-Mo Chung; Herman K Gold; Stephen M Schwartz; Yuji Ikari; Michael A Reidy; Thomas N Wight
Journal:  J Am Coll Cardiol       Date:  2002-12-18       Impact factor: 24.094

View more
  47 in total

1.  Effects of cleavage by a disintegrin and metalloproteinase with thrombospondin motifs-4 on gene expression and protein content of versican and aggrecan in the digital laminae of horses with starch gruel-induced laminitis.

Authors:  Le Wang; Erica Pawlak; Philip J Johnson; James K Belknap; Dominique Alfandari; Samuel J Black
Journal:  Am J Vet Res       Date:  2012-07       Impact factor: 1.156

2.  Distribution and processing of a disintegrin and metalloproteinase with thrombospondin motifs-4, aggrecan, versican, and hyaluronan in equine digital laminae.

Authors:  Erica Pawlak; Le Wang; Philip J Johnson; Gerard Nuovo; Almaz Taye; James K Belknap; Dominique Alfandari; Samuel J Black
Journal:  Am J Vet Res       Date:  2012-07       Impact factor: 1.156

Review 3.  ADAMTS proteases: key roles in atherosclerosis?

Authors:  Rebecca C Salter; Tim G Ashlin; Alvin P L Kwan; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2010-07-22       Impact factor: 4.599

Review 4.  Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection.

Authors:  Sean Gill; Thomas N Wight; Charles W Frevert
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

5.  Developing vasculature and stroma in engineered human myocardium.

Authors:  Kareen L Kreutziger; Veronica Muskheli; Pamela Johnson; Kathleen Braun; Thomas N Wight; Charles E Murry
Journal:  Tissue Eng Part A       Date:  2011-02-02       Impact factor: 3.845

6.  A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy.

Authors:  Richard D Kenagy; Seung-Kee Min; Eileen Mulvihill; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2011-04-14       Impact factor: 4.268

Review 7.  Extracellular matrix in the trabecular meshwork.

Authors:  Ted S Acott; Mary J Kelley
Journal:  Exp Eye Res       Date:  2008-01-25       Impact factor: 3.467

8.  Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative Immunohistochemistry.

Authors:  Jessica M Snyder; Ida M Washington; Timothy Birkland; Mary Y Chang; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2015-09-18       Impact factor: 2.479

9.  Athsq1 is an atherosclerosis modifier locus with dramatic effects on lesion area and prominent accumulation of versican.

Authors:  Sara Bretschger Seidelmann; Chaoling Kuo; Nick Pleskac; Jennifer Molina; Scott Sayers; Rong Li; Jing Zhou; Pamela Johnson; Kathleen Braun; Christina Chan; Daniel Teupser; Jan L Breslow; Thomas N Wight; Alan R Tall; Carrie L Welch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-25       Impact factor: 8.311

10.  ADAMTS-1 and ADAMTS-4 levels are elevated in thoracic aortic aneurysms and dissections.

Authors:  Pingping Ren; Lin Zhang; Gaiping Xu; Laura C Palmero; Paul T Albini; Joseph S Coselli; Ying H Shen; Scott A LeMaire
Journal:  Ann Thorac Surg       Date:  2012-12-13       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.